Kajdaniuk D, Marek B, Kos-Kudła B, Buntner B, Zwirska-Korczala K, Ostrowska Z, Nowak M
I Katedry i Zakładu Patofizjologii Slaskiej Akademii Medycznej w Katowicach.
Wiad Lek. 2000;53(5-6):283-8.
It seems, that quantitative changes of growth hormone (GH) in blood and imbalance between GH and hormones can influence the breast cancer cells proliferation, and can be a favourable element in breast cancer progression. The procedure to normalize hormonal system can have a therapeutic action. The aim of the presented work is to asses the plasma GH levels in 24 pre-menopausal women after mastectomy for breast cancer on adjuvant chemotherapy with cyclophosphamide, methotrexate, 5-fluorouracil (CMF). In this study interactions between GH and insulin like growth factor-I, prolactin, estradiol, progesterone (P), melatonin, cortisol and met-enkephalin were assessed. The control group was consisted of 16 healthy women. Plasma GH concentration and interactions between GH and studied parameters in women with breast cancer did not differ from healthy women. Highly significant positive correlation between GH and P after administration CMF was shown. CMF did not influence the interactions between GH and other studied parameters.
似乎血液中生长激素(GH)的定量变化以及GH与其他激素之间的失衡会影响乳腺癌细胞的增殖,并且可能是乳腺癌进展中的一个有利因素。使激素系统正常化的程序可能具有治疗作用。本研究的目的是评估24名绝经前乳腺癌患者在接受环磷酰胺、甲氨蝶呤、5-氟尿嘧啶(CMF)辅助化疗后乳房切除术后的血浆GH水平。在本研究中,评估了GH与胰岛素样生长因子-I、催乳素、雌二醇、孕酮(P)、褪黑素、皮质醇和甲硫氨酸脑啡肽之间的相互作用。对照组由16名健康女性组成。乳腺癌患者的血浆GH浓度以及GH与研究参数之间的相互作用与健康女性无差异。结果显示,给予CMF后GH与P之间存在高度显著的正相关。CMF不影响GH与其他研究参数之间的相互作用。